The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Review Article
Drug Therapy
PreviousPrevious
Volume 350:379-392 January 22, 2004 Number 4
NextNext

Multidisciplinary Management of Lung Cancer
Alexander Spira, M.D., Ph.D., and David S. Ettinger, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
In 2004, an estimated 173,700 Americans will receive a diagnosis of lung cancer, and 164,440 of them will die of the disease. Despite years of research, the prognosis for patients with lung cancer remains dismal, with a five-year survival rate of 14 percent. Nevertheless, lung cancer may be curable in its early stages, and most patients derive some benefit from treatment such as longer survival or amelioration of symptoms. The topic was last reviewed in the Journal in 1992.1 This review will focus on the multidisciplinary management and treatment of lung cancer, with particular emphasis on phase 3 studies.

Figure . . . [Full Text of this Article]

Principles of Radiotherapy in Lung Cancer

General Approach to Chemotherapy

Non–Small-Cell Lung Cancer

Staging and Evaluation

Surgery

Adjuvant Therapy

            Radiotherapy

            Chemotherapy

Neoadjuvant Therapy

            Nonresectable Tumors

            Resectable Tumors

            Advanced Disease

Small-Cell Lung Cancer

Limited Disease

Extensive Disease

Summary and Future Directions


Source Information

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore.

Address reprint requests to Dr. Ettinger at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bunting Blaustein Cancer Research Bldg., Rm. G88, 1650 Orleans St., Baltimore, MD 21231-1000, or at ettinda@jhmi.edu.


Related Letters:

Multidisciplinary Management of Lung Cancer
Jacobson B. C., Gould M. K., Silvestri G. A., Detterbeck F., Papagiannis A., Buyukcelik A., Yalcin B., Utkan G., Spira A., Ettinger D. S.
Extract | Full Text | PDF  
N Engl J Med 2004; 350:2008-2010, May 6, 2004. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.